Nebla, Arnulfo S.

HRN: 17-40-46  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/04/2024
CEFTRIAXONE 1G (VIAL)
08/04/2024
08/10/2024
IV
2g
OD
Choledocholithiases
Waiting Final Action 
08/09/2024
AZITHROMYCIN 500MG TABLET (TAB)
08/09/2024
08/13/2024
IM
500mg
OD
CAP MR
Waiting Final Action 
08/13/2024
CIPROFLOXACIN 500MG (TAB)
08/13/2024
08/19/2024
ORAL
500mg
BID
UTI
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: